These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 18555017)

  • 1. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
    Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.
    Wong QW; Ching AK; Chan AW; Choy KW; To KF; Lai PB; Wong N
    Clin Cancer Res; 2010 Feb; 16(3):867-75. PubMed ID: 20103675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
    Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
    Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
    Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
    Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
    Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
    Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
    Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.
    Lin CJ; Gong HY; Tseng HC; Wang WL; Wu JL
    Biochem Biophys Res Commun; 2008 Oct; 375(3):315-20. PubMed ID: 18692484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
    Diao S; Zhang JF; Wang H; He ML; Lin MC; Chen Y; Kung HF
    Proteomics; 2010 Oct; 10(20):3723-31. PubMed ID: 20859956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
    Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
    Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
    Murakami Y; Yasuda T; Saigo K; Urashima T; Toyoda H; Okanoue T; Shimotohno K
    Oncogene; 2006 Apr; 25(17):2537-45. PubMed ID: 16331254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
    Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
    Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of miR-122a and miR-224 expression in hepatocellular carcinoma by real-time fluorescence quantitative RT-PCR].
    Liu ZR; Chen XW; Qiao XH; Wang R; Xiang Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):751-3. PubMed ID: 19403413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
    Iizuka N; Oka M; Yamada-Okabe H; Hamada K; Nakayama H; Mori N; Tamesa T; Okada T; Takemoto N; Matoba K; Takashima M; Sakamoto K; Tangoku A; Miyamoto T; Uchimura S; Hamamoto Y
    Int J Oncol; 2004 Mar; 24(3):565-74. PubMed ID: 14767541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis.
    Huang YS; Dai Y; Yu XF; Bao SY; Yin YB; Tang M; Hu CX
    J Gastroenterol Hepatol; 2008 Jan; 23(1):87-94. PubMed ID: 18171346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MicroRNA profiling in patients with hepatocellular carcinoma].
    Wang CX; Song W; Li ZJ; Song B; Wu DH; Sun AM; Chen LH
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):976-7. PubMed ID: 20501372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.